tropmedpharma.com Report : Visit Site

Technical data of the tropmedpharma.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host tropmedpharma.com. Currently, hosted in Germany and its service provider is 1&1 Internet AG .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

get in contact — main menu — home how we work our expertise recommendations news & publications - news - - latest news - - comments - - archive - publications - - amfm - - crimalddi - - global fund - - governmental organisations - - roll back malaria - - presentations & conferences - - other publications useful links contact us home how we work our expertise recommendations news & publications news latest news comments archive publications amfm crimalddi global fund governmental organisations roll back malaria presentations & conferences other publications useful links contact us welcome to tropmed pharma consulting tropmed pharma consulting specialises in advising companies, academic institutions, non-governmental organisations (ngos), and governmental and intergovernmental organisations working on malaria and neglected tropical diseases to help them be more successful. the challenges in this field are often different from those faced by projects in other areas of medicine. most projects in this area are carried out in the form of public-private partnerships (ppps) or product development partnerships (pdps). the involvement of many different parties from the public and private spheres, with different objectives, skill sets, and expertise can raise challenges that have often not been experienced before by the organisations involved. ian boulton (managing director) brings more than 30 years experience in the pharmaceutical industry and over 15 years working in this field to meeting tropmed pharma consulting’s mission. he has been involved in many public-private partnerships and so has experiences (good and bad) to draw on and inform the advice to our clients. mission statement tropmed pharma consulting specialises in advising companies, academic institutions, non-governmental organisations (ngos), and governmental and intergovernmental organisations working on malaria and neglected tropical diseases to help them be more successful. about our work planning, r & d, building partnerships and encouraging best practice are key to our success. we work closely with pharmaceutical companies, private and public sector organisations to develop robust strategies in the discovery, development, and deployment of new drugs. more our expertise ian boulton has over 30 years' experience working in the pharmaceutical industry, r&d;, sales, marketing, business development, strategic planning, & general management. he is recognised as a leading figure in the global effort to control, eliminate, and ultimately eradicate malaria and other tropical diseases. more client recommendations prof trevor jones ian is one of the leading world experts on drug discovery, development, and accessibility of medicines for the developing world. his expertise across a wide range of infectious diseases that primarily afflict patients in the developing world is broad-based - ranging from drug design,through clinical development and delivery, to healthcare systems.he has been singularly helpful in advising international organisations and pharmaceutical companies in this field. (january 11, 2013) president, sigma tau pharmaceuticals inc.: formerly director-general, abpi; director of r&d, wellcome foundation alan court i have known ian for several years, working with him and also sitting on the same board and in different working groups and task forces of the roll back malaria board. he is an outstanding colleague who has a capacity to turn multiple and diverse pieces of information into a coherent plan or recommendation having carefully validated with all stakeholders. he is a first-rate analyst who is able to put together plans and budgets as well as set up systems, giving him a diverse capacity useful for any organization whether a start-up, under reorganization or evaluation. this is in addition to his own area of pharmaceuticals where he is also a valuable asset. ian also writes well, clearly and concisely. a wonderful colleague and a thorough professional. (27 september 2010) senior advisor - un secretary general’s special envoy for malaria prof steve ward i first worked with ian when he was with glaxosmithkline and representing them in a public-private partnership aimed at developing & delivering affordable and safe antimalarial drugs. what was most striking at the time was ian's immediate grasp of the most relevant scientific issues we had to deal with, his eye for the problems that might blight our progress, and his professional and pragmatic approach to overcoming these difficulties. it was these qualities and his excellent facilitating skills that convinced me to ask ian to work with us on an important eu-funded consortium focused on setting the antimalarial drug r&d agenda for the next decade. the success of this project has in large part been down to ian's ability to identify key opinion leaders and co-ordinate, convene, and facilitate a complex series of meetings and workshops. ian has managed to engage quite senior academics in innovative "brain-storming" sessions in order to get a fresh view on the issues and the potential ways forward. this has been stimulating, engaging, and - most importantly - highly effective. (april 23, 2010). deputy director, liverpool school of tropical medicine steven c phillips i worked directly with ian as private sector representative on the board of roll back malaria. ian is very knowledgeable about business sector issues relating to neglected diseases, ranging from manufacturing to distribution, marketing and sales. he is an excellent communicator and strategist, and works well building coalitions within and across sectors. it was a privilege to work with him over 4 years. (october 26, 2008) senior fellow, chatham house: formerly medical director - global issues and projects, exxon mobil corporation matt lynch ian is a valued and highly-professional consultant and colleague. he worked very hard under a tight timeline and politically charged atmosphere to deliver an extremely well-written and useful document for the executive committee of the rbm board.. this provided the background needed to develop consensus and move a potentially divisive issue towards resolution. ian has served with me on the rbm board, and is a strong contributor to the success of the private sector delegation on that board. (january 23, 2013) director of global program on malaria, center for communication programs, bloomberg school of public health, johns hopkins university david brandling-bennett during my 10 years with the bill and melinda gates foundation, i have had multiple opportunities to work with ian, especially since joining the rbm board in 2008. both as a rbm board member himself and subsequently as a consultant, ian has brought the rigorous thinking and experience of the private sector to a largely public sector oriented partnership. his knowledge of market dynamics and the vital but often poorly understood role of the private sector was critical to the success of the affordable medicines facility for malaria (amfm), which showed clearly that access through the private sector to quality affordable antimalarial drugs could be increased significantly. with his knowledge and experience in the full range of drug discovery, development, and delivery, ian can provide essential support to all those seeking to improve access by under-served populations to life-saving commodities, especially by using his skills working with both the private and public sectors. (26 june 2014) senior advisor - malaria, global health division, bill & melinda gates foundation more recommendations articles & documents publications latest news comments archive useful links disease information organisations current awareness useful journals contact us tropmed pharma consulting 10 brampton chase lower shiplake oxfordshire rg9 3bx uk tel: +44 (118) 940 3349 fax: +44 (118) 940 3349 email us copyright tropmed pharma consulting 2014 all rights reserved

URL analysis for tropmedpharma.com

http://www.tropmedpharma.com/latest-news
http://www.tropmedpharma.com/useful-links/
http://www.tropmedpharma.com/publications/roll-back-malaria/
http://www.tropmedpharma.com/publications/global-fund/
http://www.tropmedpharma.com/contact-us/
http://www.tropmedpharma.com/publications/amfm/
http://www.tropmedpharma.com/publications/roll-back-malaria-2/
http://www.tropmedpharma.com/comments/
http://www.tropmedpharma.com/publications/crimalddi/
http://www.tropmedpharma.com/expertise/
http://www.tropmedpharma.com/recommendations/
http://www.tropmedpharma.com/publications/other-publications/
http://www.tropmedpharma.com/publications/governmental-organisations/
http://www.tropmedpharma.com/how-we-work/
http://www.tropmedpharma.com/archive/
tmpc.netmailing.co.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: TROPMEDPHARMA.COM
Registry Domain ID: 1511401542_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucowsdomains.com
Updated Date: 2017-07-24T18:24:55Z
Creation Date: 2008-07-31T21:33:41Z
Registry Expiry Date: 2018-07-31T21:33:41Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS-UK.1AND1-DNS.BIZ
Name Server: NS-UK.1AND1-DNS.CO.UK
Name Server: NS-UK.1AND1-DNS.COM
Name Server: NS-UK.1AND1-DNS.ORG
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-10-14T01:20:43Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Tucows Domains Inc.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =tropmedpharma.com

  PORT 43

  TYPE domain

DOMAIN

  NAME tropmedpharma.com

  CHANGED 2017-07-24

  CREATED 2008-07-31

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS-UK.1AND1-DNS.BIZ 217.160.81.3

  NS-UK.1AND1-DNS.CO.UK 217.160.80.3

  NS-UK.1AND1-DNS.COM 217.160.82.3

  NS-UK.1AND1-DNS.ORG 217.160.83.3

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .